 |
Also known as: Epifrin, Epinal, Eppy/N, Glaucon
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Epinephrine.
No reviews have yet been submitted. Be the first to review this drug.
Pregnancy Category Risk cannot be ruled out
WHITEHOUSE STATION, N.J., Feb. 13, 2012 – Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug...
People who use cocaine are 45 percent more likely to develop open-angle glaucoma, the most common form of the eye disease, according to a new study. The study...
Spending on medications for Americans with the eye disease glaucoma has increased overall and especially among certain groups of patients, a new study...
Mar 9, 2011 - Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application (NDA) for Saflutan (tafluprost),...
Obesity may be associated with reduced risk of the eye disease open-angle glaucoma in women, but not in men, a new study suggests. Open-angle glaucoma is the...
Looking for answers? Ask a question or go join the epinephrine support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
